Abivax ABVX
NASDAQ ABVX
$96.85 +5.79 (+6.36%)
At close: Sep 28, 2026 · 4:00 PM EDT

Abivax (ABVX) Non-Current Deferred Tax Liability (2025 - 2026)

Updated

Abivax's Non-Current Deferred Tax Liability was $7.11 billion in Q1 2026.

Analysis

Abivax (ABVX) Non-Current Deferred Tax Liability (2025 - 2026) Analysis & Trends

At the end of FY2025, Non-Current Deferred Tax Liability at Abivax came in at $6.61 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn
10 Abivax 7.15 Bn 7.15 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 7.11 Bn
Dec 31, 2025 6.81 Mn
API Access

Abivax Non-Current Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deferred-tax-liability&ticker=ABVX&period=max&api_key=YOUR_API_KEY